Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

Objective. Interstitial lung disease (ILD) is a common extra-articular manifestation of rheumatoid arthritis (RA) and a significant cause of morbidity and mortality. The objective of this study was to define high-resolution chest CT (HRCT) and pulmonary function test (PFT) abnormalities capable of...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Chen, YongHong Shi, XiaoPing Wang, Heqing Huang, Dana Ascherman
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2013/406927
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162236906012672
author Juan Chen
YongHong Shi
XiaoPing Wang
Heqing Huang
Dana Ascherman
author_facet Juan Chen
YongHong Shi
XiaoPing Wang
Heqing Huang
Dana Ascherman
author_sort Juan Chen
collection DOAJ
description Objective. Interstitial lung disease (ILD) is a common extra-articular manifestation of rheumatoid arthritis (RA) and a significant cause of morbidity and mortality. The objective of this study was to define high-resolution chest CT (HRCT) and pulmonary function test (PFT) abnormalities capable of identifying asymptomatic, preclinical forms of RA-ILD that may represent precursors to more severe fibrotic lung disease. Methods. We analyzed chest HRCTs in consecutively enrolled RA patients and subsequently classified these individuals as RA-ILD or RA-no ILD based on the presence/absence of ground glass opacification, septal thickening, reticulation, traction bronchiectasis, and/or honeycombing. Coexisting PFT abnormalities (reductions in percent predicted FEV1, FVC, TLC, and/or DLCO) were also used to further characterize occult respiratory defects. Results. 61% (63/103) of RA patients were classified as RA-ILD based on HRCT and PFT abnormalities, while 39% (40/103) were designated as RA-no ILD. 57/63 RA-ILD patients lacked symptoms of significant dyspnea or cough at the time of HRCT and PFT assessment. Compared with RA-no ILD, RA-ILD patients were older and had longer disease duration, higher articular disease activity, and more significant PFT abnormalities. Conclusion. HRCT represents an effective tool to detect occult/asymptomatic ILD that is highly prevalent in our unselected, university-based cohort of RA patients.
format Article
id doaj-art-faadb43f297b4e1aa05f654000f3db21
institution OA Journals
issn 1740-2522
1740-2530
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-faadb43f297b4e1aa05f654000f3db212025-08-20T02:22:37ZengWileyClinical and Developmental Immunology1740-25221740-25302013-01-01201310.1155/2013/406927406927Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung DiseaseJuan Chen0YongHong Shi1XiaoPing Wang2Heqing Huang3Dana Ascherman4Rheumatology Department of the First Hospital of Xiamen University, Zhen Hai Road No. 55, Xiamen 361003, ChinaPulmonary Department of the First Hospital of Xiamen University, Zhen Hai Road No. 55, Xiamen 361003, ChinaRadiology Department of the First Hospital of Xiamen University, Zhen Hai Road No. 55, Xiamen 361003, ChinaRheumatology Department of the First Hospital of Xiamen University, Zhen Hai Road No. 55, Xiamen 361003, ChinaUniversity of Miami School of Medicine, Miami, FL 33136, USAObjective. Interstitial lung disease (ILD) is a common extra-articular manifestation of rheumatoid arthritis (RA) and a significant cause of morbidity and mortality. The objective of this study was to define high-resolution chest CT (HRCT) and pulmonary function test (PFT) abnormalities capable of identifying asymptomatic, preclinical forms of RA-ILD that may represent precursors to more severe fibrotic lung disease. Methods. We analyzed chest HRCTs in consecutively enrolled RA patients and subsequently classified these individuals as RA-ILD or RA-no ILD based on the presence/absence of ground glass opacification, septal thickening, reticulation, traction bronchiectasis, and/or honeycombing. Coexisting PFT abnormalities (reductions in percent predicted FEV1, FVC, TLC, and/or DLCO) were also used to further characterize occult respiratory defects. Results. 61% (63/103) of RA patients were classified as RA-ILD based on HRCT and PFT abnormalities, while 39% (40/103) were designated as RA-no ILD. 57/63 RA-ILD patients lacked symptoms of significant dyspnea or cough at the time of HRCT and PFT assessment. Compared with RA-no ILD, RA-ILD patients were older and had longer disease duration, higher articular disease activity, and more significant PFT abnormalities. Conclusion. HRCT represents an effective tool to detect occult/asymptomatic ILD that is highly prevalent in our unselected, university-based cohort of RA patients.http://dx.doi.org/10.1155/2013/406927
spellingShingle Juan Chen
YongHong Shi
XiaoPing Wang
Heqing Huang
Dana Ascherman
Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
Clinical and Developmental Immunology
title Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
title_full Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
title_fullStr Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
title_full_unstemmed Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
title_short Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
title_sort asymptomatic preclinical rheumatoid arthritis associated interstitial lung disease
url http://dx.doi.org/10.1155/2013/406927
work_keys_str_mv AT juanchen asymptomaticpreclinicalrheumatoidarthritisassociatedinterstitiallungdisease
AT yonghongshi asymptomaticpreclinicalrheumatoidarthritisassociatedinterstitiallungdisease
AT xiaopingwang asymptomaticpreclinicalrheumatoidarthritisassociatedinterstitiallungdisease
AT heqinghuang asymptomaticpreclinicalrheumatoidarthritisassociatedinterstitiallungdisease
AT danaascherman asymptomaticpreclinicalrheumatoidarthritisassociatedinterstitiallungdisease